Nanosuspension improves tretinoin photostability and delivery to the skin.

The aims of this work were to improve cutaneous targeting and photostability of tretinoin by using nanosuspension formulation. Tretinoin is a drug widely used in the topical treatment of various dermatological diseases. The tretinoin nanosuspension was prepared by precipitation method and then characterized by photo correlation spectroscopy for mean size and size distribution, and by transmission electron microscopy for morphological studies. An oil in water tretinoin nanoemulsion was also prepared and used as a control. Dermal and transdermal delivery of both tretinoin nanosuspension and nanoemulsion were tested in vitro by using Franz diffusion cells and newborn pig skin. Photodegradation studies were carried out by UV irradiation (1h, λ=366 nm) of the tretinoin nanosuspension in comparison with the nanoemulsion and a methanolic solution of the drug. During 8h percutaneous experiments, the nanosuspesion was able to localize the drug into the pig skin with a very low transdermal drug delivery, whereas the nanoemulsion greatly improved drug permeation. UV irradiation of the nanosuspension showed a great improvement of tretinoin stability in comparison with both controls. Overall results show that nanosuspension might be a useful formulation for improving tretinoin dermal delivery and stability.

[1]  C. Lehr,et al.  Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  A. Fadda,et al.  Niosomes as carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin photostability. , 2003, International journal of pharmaceutics.

[3]  Joseph Wong,et al.  Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. , 2008, Advanced drug delivery reviews.

[4]  A. Fadda,et al.  Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. , 2011, International journal of pharmaceutics.

[5]  Rainer H Müller,et al.  State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  Fars K Alanazi,et al.  Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview , 2012, Expert opinion on drug delivery.

[7]  Jun Li,et al.  Preparation and characterization of intravenously injectable nimodipine nanosuspension. , 2008, International journal of pharmaceutics.

[8]  R. Müller,et al.  Lutein nanocrystals as antioxidant formulation for oral and dermal delivery. , 2011, International journal of pharmaceutics.

[9]  Hong-Duo Chen,et al.  The application of nanoemulsion in dermatology: an overview , 2013, Journal of drug targeting.

[10]  R. Müller,et al.  Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration , 2002, Pharmaceutical Research.

[11]  A. Fadda,et al.  Nanoemulsions as Vehicle for Topical 8-Methoxypsoralen Delivery , 2008 .

[12]  G. Amidon,et al.  Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. , 2004, Molecular pharmaceutics.

[13]  Gordon L Amidon,et al.  A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals , 2002, Journal of clinical pharmacology.

[14]  Jiraporn Chingunpituk.  Nanosuspension Technology for Drug Delivery , 2011 .

[15]  R. Müller,et al.  Resveratrol nanosuspensions for dermal application--production, characterization, and physical stability. , 2009, Die Pharmazie.

[16]  Madhu Gupta,et al.  Nanocarrier-based topical drug delivery for the treatment of skin diseases , 2012, Expert opinion on drug delivery.

[17]  Rainer H. Müller,et al.  Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. , 2013, International journal of pharmaceutics.

[18]  A. Fadda,et al.  Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. , 2006, International journal of pharmaceutics.

[19]  Barrett E. Rabinow,et al.  Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.

[20]  Marcello Peppi,et al.  Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Kumar A. Shah,et al.  Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. , 2007, International journal of pharmaceutics.

[22]  G. Ennas,et al.  Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. , 2009, International journal of pharmaceutics.

[23]  C. Surber,et al.  Topical retinoids in the management of photodamaged skin: from theory to evidence‐based practical approach , 2010, The British journal of dermatology.

[24]  G. Angioni,et al.  Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[25]  M Brisaert,et al.  Investigation on the photostability of a tretinoin lotion and stabilization with additives. , 2000, International journal of pharmaceutics.

[26]  Filippos Kesisoglou,et al.  Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.

[27]  Rainer H. Müller,et al.  Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique , 1998 .

[28]  Vandana B. Patravale,et al.  Current strategies for engineering drug nanoparticles , 2004 .

[29]  Yann-Lii Leu,et al.  Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. , 2003, International journal of pharmaceutics.

[30]  C. Zouboulis.  Retinoids – Which Dermatological Indications Will Benefit in the Near Future? , 2001, Skin Pharmacology and Physiology.

[31]  Rainer H Müller,et al.  Production and characterization of Hesperetin nanosuspensions for dermal delivery. , 2009, International journal of pharmaceutics.

[32]  Gordon L. Amidon,et al.  Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size , 1996, Pharmaceutical Research.

[33]  M. Ghorab,et al.  Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. , 2007, International journal of pharmaceutics.

[34]  B. Parodi,et al.  Study of retinoic acid polymorphism. , 2006, Journal of pharmaceutical sciences.